Click here to access the 2017 calendar of Global Healthcare Conferences compiled by OBIO for its members
upcoming obio events
Recent OBIO Events
On November 27th, OBIO held its 9th Annual Public Meeting at offices of Norton Rose Fulbright. It was an exciting event with a formidable Keynote, a packed room of industry leaders, and an excellent venue for networking!
Regulatory and Business Strategy
Joel Ironstone is a medical technology development expert with over 15 years of consulting experience developing novel medical technologies. His experience includes technical development, regulatory approvals and the design and execution of clinical trials.
Presented by Bausch + Lomb
Bausch + Lomb is a subsidiary division of the multinational specialty pharmaceutical company, Valeant Pharmaceuticals International, located in Quebec, Canada. B+L operates within the health care and optics space, with a major focus on marketing, sales and distribution of vision care products.
Looking for the latest funding programs or a valuable partnership? Go beyond combing websites and come to OBIO's “Meet the Non-Dilutive Money!”
Representatives will be Live & In Person from:
- Ontario Centres of Excellence (OCE)
- Ontario Genomics Institute (OGI)
OBIO’s ½ day workshop on health economics, in partnership with and hosted by St. Michael’s Hospital Toronto, will include the following topics:
- The role of payors in healthcare technology adoption in major jurisdictions
- Understanding, designing and executing trials to show product value
- Pricing and market access strategies driven by Health Economics
Upcoming Industry Events
Recent Industry Events
The Canadian Global Initiative Against Alzheimer's Disease presents the 2nd Alzheimer's Awareness Gala
Monday, December 18, 2017
5:30pm - 10pm
Fairmont Royal York, Toronto, Ontario
This years' keynote speakers include Dr. Serge Gauthier, Dr. Michael Gold, and Prof K. Yogesan.
- Dr. Gauthier, C.M., MD, FRCPC, is the Director of the Alzheimer's Disease Research Unit, McGill University Research Centre for Studies in Aging.
- Dr. Gold is Vice-President, Development Neurosciences, at AbbVie.
- Professor Yogesan is a Professor at the School of Medicine, University of Notre Dame, and a Visiting Scholar at Harvard University.
Keynote speaker, David Rosenberg, Chief Economist, Gluskin Sheff + Associates, will be speaking about 'Living with Lower for Longer', the event will be in support of research on the impact of Age-Related Macular Degeneration (AMD) by Dr. Shelley Boyd, CEO of Translatum Medicus.
Monday December 4th, 2017
Hosted at JLabs Toronto
On November 23rd, Tanja Dowe, CEO, and Tom Gibbs, Director, of Debiopharm Innovation Fund S.A will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.
Join us for an expert-led overview of what you need to know in order to market drugs in the U.S. while being FDA compliant. This webinar features leading regulatory attorneys from Hyman, Phelps & McNamara (HMP), who will provide an overview of FDA laws, what typically foes wrong in regulatory strategies and submissions, and best practices to ensure you stay on the market in the U.S. and remain compliant with applicable laws. Leading regulatory attorneys from Torys LLP will also provide a Canadian law perspective.